Endo International has revealed that its Par Sterile Products division is now shipping posaconazole injection (18 mg/mL) in the United States. This marks the first generic version of Merck’s Noxafil, following the final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application. Posaconazole injection is prescribed for the prevention […]
Dr. Reddy’s Laboratories said that it has launched Posaconazole Delayed-Release Tablets, 100 mg, a triazole antifungal drug, in the US market. Posaconazole Delayed-Release Tablets is the therapeutic generic equivalent to NOXAFIL (posaconazole) Delayed-Release Tablets, 100 mg, which has approval from the US Food and Drug Administration. According to IQVIA, the NOXAFIL brand and generic had […]
Bajaj Healthcare Limited (BHL) has launched “Posaconazole API”, the active pharmaceutical ingredient (API) of the triazole antifungal agent Posaconazole, used in the treatment of Mucormycosis (Black Fungus) infection in patients with Covid-19. The APIs, intermediates, and formulations manufacturer has secured approval from Food & Drug Control Administration (FDA) Gandhi Nagar, Gujarat (India) for manufacturing and […]
Everest Organics Limited said that it has developed and launched Posaconazole, an anti-fungal API for the treatment of black fungus associated with Covid-19 patients. Posaconazole is a triazole antifungal agent indicated for treating mucormycosis (or Black Fungus) which has become prevalent in several Covid patients during the second wave in India. Dr. Srikakarlapudi Sirisha – […]